Stay updated on Ramucirumab vs Docetaxel in Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the Ramucirumab vs Docetaxel in Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ramucirumab vs Docetaxel in Bladder Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The record for this Phase 2 bladder and urinary-tract cancer trial is displayed, including its treatment arms, eligibility criteria, outcome measures, and participant data-sharing plan. The study is marked completed and no longer recruiting.
    Difference
    76%
    Check dated 2026-11-08T15:31:58.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0. The study record page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T16:25:59.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide notice announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:48:36.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T22:26:20.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-11T22:24:18.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden error, replacing the expected study details with an error page. This appears to be a permissions or server issue rather than a content update.
    Difference
    20%
    Check dated 2026-09-20T22:38:18.000Z thumbnail image

Stay in the know with updates to Ramucirumab vs Docetaxel in Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ramucirumab vs Docetaxel in Bladder Cancer Clinical Trial page.